 |
|
MIT uncovers key blood protein
October 12, 2007Discovery could lead to new therapeutics for certain blood diseases
CAMBRIDGE, MA--Scientists working in the only lab at MIT doing hematology research have uncovered a protein that plays a key role in the recycling of iron from blood.
Their work, described in the October 11 Journal of Clinical Investigation, could lead to new therapies for certain inherited blood disorders such as beta-thalassemia, a condition that causes chronic anemia. The team is led by Jane-Jane Chen, a principal research scientist in the Harvard-MIT Division of Health Sciences and Technology (HST).
Two years ago Chen and colleagues showed that a protein, heme-regulated eukaryotic translational initiation factor 2 ±-subunit (eIF2-alpha) kinase, or HRI for short, keeps mice with beta-thalassemia alive. This protein minimizes an abnormal and toxic imbalance of globin chains, the protein base for the hemoglobin found in red blood cells. Hemoglobin carries oxygen to our organs and carts away carbon dioxide waste.
In the new work, the team has found that HRI also plays a key role in the body's iron recycling process. Chen observed that this process falters in mice lacking HRI. As a result, less iron was available for use in the creation of new red blood cells.
A closer look revealed that HRI influences two mechanisms in this recycling process. First, a lack of HRI reduces levels of another protein called hepcidin. Hepcidin, recently discovered to be the master regulator of the iron cycle, releases iron from stores in the body and makes it available to be processed into hemoglobin. Without hepcidin, the body retains iron, but never puts it to work.
The team also found that HRI, which is expressed predominantly in the precursors of red blood cells, is expressed in macrophages. Macrophages are cells that literally reach out and grab dying red blood cells and eat them, digesting them and releasing the iron from their hemoglobin back into the system.
A lack of HRI causes these macrophages to lose their appetite, gobbling down fewer red blood cells. Instead of being digested and recycled, the red blood cells die and end up excreted through the kidneys. The result is a net loss of iron from the body.
With this new understanding of HRI's dual role in iron recycling-that it both keeps iron in the body and puts it to work-Chen is conducting a search for small molecules that might modulate the HRI signaling pathway. In turn, these compounds could potentially help diseased precursors of red blood cells survive and boost the iron recycling process.
"Perhaps we will find a compound that could help patients with beta-thelassemia or other diseases where HRI plays a role," said Chen. Such conditions include a genetic disorder called erythropoietic protoporphyria (EPP), which causes photosensitivity and liver disease, as well as a condition called the anemia of inflammation in which the iron recycling process breaks down under the influence of stress, chronic disease, aging, or cancer.
Massachusetts Institute of Technology
Two years ago Chen and colleagues showed that a protein, heme-regulated eukaryotic translational initiation factor 2 ±-subunit (eIF2-alpha) kinase, or HRI for short, keeps mice with beta-thalassemia alive. This protein minimizes an abnormal and toxic imbalance of globin chains, the protein base for the hemoglobin found in red blood cells. Hemoglobin carries oxygen to our organs and carts away carbon dioxide waste.
In the new work, the team has found that HRI also plays a key role in the body's iron recycling process. Chen observed that this process falters in mice lacking HRI. As a result, less iron was available for use in the creation of new red blood cells.
A closer look revealed that HRI influences two mechanisms in this recycling process. First, a lack of HRI reduces levels of another protein called hepcidin. Hepcidin, recently discovered to be the master regulator of the iron cycle, releases iron from stores in the body and makes it available to be processed into hemoglobin. Without hepcidin, the body retains iron, but never puts it to work.
The team also found that HRI, which is expressed predominantly in the precursors of red blood cells, is expressed in macrophages. Macrophages are cells that literally reach out and grab dying red blood cells and eat them, digesting them and releasing the iron from their hemoglobin back into the system.
A lack of HRI causes these macrophages to lose their appetite, gobbling down fewer red blood cells. Instead of being digested and recycled, the red blood cells die and end up excreted through the kidneys. The result is a net loss of iron from the body.
With this new understanding of HRI's dual role in iron recycling-that it both keeps iron in the body and puts it to work-Chen is conducting a search for small molecules that might modulate the HRI signaling pathway. In turn, these compounds could potentially help diseased precursors of red blood cells survive and boost the iron recycling process.
"Perhaps we will find a compound that could help patients with beta-thelassemia or other diseases where HRI plays a role," said Chen. Such conditions include a genetic disorder called erythropoietic protoporphyria (EPP), which causes photosensitivity and liver disease, as well as a condition called the anemia of inflammation in which the iron recycling process breaks down under the influence of stress, chronic disease, aging, or cancer.
Massachusetts Institute of Technology
Blood Cell Current Events and Blood Cell News RSSResearcher tricks immune system in diabetic mice
The body's immune system hates strangers. When its security patrol spots a foreign cell, it annihilates it.
Researchers shed new light on catalyzed reactions
Rice University scientists on the hunt for a better way to clean up the stubborn pollutant TCE have created a method that lets them watch molecules break down on the surface of a catalyst as individual chemical bonds are formed and broken.
Preventing anemia is important to kidney disease patients' quality of life
Maintaining sufficient red blood cell levels is important to the physical and mental health of patients with chronic kidney disease (CKD), according to a study appearing in the January 2009 issue of the Clinical Journal of the American Society Nephrology (CJASN). The findings indicate that preventing anemia in kidney disease patients should be an integral part of their care.
Mayo Clinic Researchers Find Predictive Tests and Early Treatment Delay Progression of Blood Cell Cancer
Mayo Clinic researchers say they have moved closer to their goal of providing personalized care for a common blood cell cancer.
Researchers describe how chronic inflammation can lead to stomach cancer
A multi-center research team, led by Columbia University Medical Center, has uncovered a major contributor to the cause of stomach cancer - the second leading cause of cancer-related mortality in the world.
Proteomics Study Yields Clues As To How Tuberculosis Might Be Thwarting The Immune System
A link between the immune system and the self-cleaning system by which biological cells rid themselves of obsolete or toxic parts may one day yield new weapons in the fight against tuberculosis and other deadly infectious diseases.
Syracuse University researchers discover new way to attack some forms of leukemia
Each year, some 29,000 adults and 2,000 children are diagnosed with leukemia, a form of cancer that is caused by the abnormal production of white blood cells in the bone marrow.
Making flies sick reveals new role for growth factors in immunity
A Salmonella infection is not a positive experience. However, by infecting the common laboratory fruit fly Drosophila melanogaster with a Salmonella strain known for causing humans intestinal grief, researchers in the School of Life Sciences at Arizona State University have shed light on some key cell regulatory processes - with broad implications for understanding embryonic development, immune function and congenital diseases in humans.
Silencing a protein could kill T-Cells, reverse leukemia
Blocking the signals from a protein that activates cells in the immune system could help kill cells that cause a rare form of blood cancer, according to physicists and oncologists who combined computer modeling and molecular biology in their discovery.
New hope for multiple sclerosis sufferers
A drug which was developed in Cambridge and initially designed to treat a form of leukaemia has also proven effective against combating the debilitating neurological disease multiple sclerosis (MS).
More Blood Cell Current Events and Blood Cell News Articles
 | Blood Cells An Atlas of Morphology with Clinical Relevance by Gene Gulati and Jaime Caro Dr Gene L. Gulati, world-renowned educator and frequent contributor to Laboratory Medicine and other prestigious scientific journals, along with his colleague Dr. Jaime Caro, have brought together a comprehensive and completely practical color atlas of the characteristics and clinical relevance of individual normal and abnormal cells, and the morphologic findings associated with various clinical... |
 | Bone Marrow and Blood Stem Cell Transplants: A Guide For Patients by Susan Stewart Bone Marrow and Stem Cell Transplants: A Guide for Patients is the next generation of Susan K. Stewart's groundbreaking 1992 book Bone Marrow Transplants: A Book of Basics for Patients. This new 228 paage guide combines solid medical information with the voices of people who have been through a transplant. Comprehensive and easy-to-read, Bone Marrow and Blood Stem Cell Transplants: A Guide for... |
 | Blood Cells: A Practical Guide by Barbara J. Bain Blood Cells has been written with both the practising haematologist and the trainee in mind. It aims to provide a guide for use in the diagnostic haematology laboratory, covering methods of collection of blood specimens, blood film preparation and staining, the principles of manual and automated blood counts and the assessment of the morphological features of blood cells. The practising... |
 | A Beginner's Guide to Blood Cells by Barbara J. Bain This popular pocket book has been updated and expanded throughout, providing a concise view of diagnostic haematology, in a convenient and practical format.A Beginner's Guide to Blood Cells is an ideal for;Trainee laboratory technicians and scientists Students studying the physiology or pathology of the blood Those preparing for haematology examinationsWhy Buy This Book?Unique pocket guide,... |
 | The White Stripes - White Blood Cells by The White Stripes Here's the matching folio to the acclaimed 2001 breakthrough from this Detroit duo, darlings of the international music media. Note-for-note tab transcriptions of Jack White's playing on 16 tracks: Aluminum * Dead Leaves and the Dirty Ground * Fell in Love with a Girl * Hotel Yorba * I Can't Wait * I Think I Smell a Rat * I'm Finding It Harder to Be a Gentleman * Offend in Every Way * The Union... |
| The Morphology of Human Blood Cells, 5th Edition by Diggs; Sturm; Bell | |
 | In the Blood: Sickle Cell Anemia and the Politics of Race (Critical Histories) by Melbourne Tapper Although it strikes individuals from a variety of backgrounds, sickle cell anemia has always been known as a "black" disease in America. In the Blood argues that ever since the discovery in 1910 and subsequent scientific analysis of the disease, sickle cell anemia has been manipulated to serve social ends-as a tool for securing white identity and a way to establish a hierarchy based on European... |
| The Morphology of Human Blood Cells by Ann Bell, Sabah Sallah Model # from back of book 97-1511/R13-10 October... | |
| Morphology of Human Blood Cells by L W Diggs | |
 | Color Atlas and Instruction Manual of Peripheral Blood Cell Morphology by Barbara H O'Connor This essential guide can help readers identify blood type cells, which are difficult to categorize, and explains the morphologic characteristics of peripheral blood cells in detail. Some of the book's features include: color photographs that depict each stage of cell maturation in the exact sequence of development; comparative photographs of difficult-to-identify cells from different cell lines... |
| © 2008 BrightSurf.com |